MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway
Ghmkin Hassan, Said M. Afify, Juan Du, Hend M. Nawara, Mona Sheta, Sadia Monzur, Maram H. Zahra, Hagar A. Abu Quora, Hager Mansour, Samah El-Ghlban, Ryo Uesaki, Akimasa Seno, Masaharu Seno
Research output: Contribution to journal › Article › peer-review
5Scopus
citations
Fingerprint
Dive into the research topics of 'MEK1/2 is a bottleneck that induces cancer stem cells to activate the PI3K/AKT pathway'. Together they form a unique fingerprint.